Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Orme, R.C., Hanson, J. et al. (11 more authors) (2019) Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets, 30 (2). pp. 148-157. ISSN 0953-7104

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Aspirin; P2Y inhibitors; bleeding; thromboxane; ticagrelor
Dates:
  • Accepted: 11 January 2019
  • Published (online): 13 February 2019
  • Published: 13 February 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
BRITISH HEART FOUNDATIONFS/15/82/31824
Depositing User: Symplectic Sheffield
Date Deposited: 07 Mar 2019 11:59
Last Modified: 18 Nov 2021 09:44
Status: Published
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1080/09537104.2019.1572880
Related URLs:

Export

Statistics